Life exists in motion. CellChorus® provides a high-throughput platform for evaluating how individual cells move, behave and interact.
Houston, TX | South SF, CA
Joined July 2020
- Tweets145
- Following54
- Followers100
- Likes324
CellChorus retweeted
Trump’s decision to halt federal virtually all federal grants and loans is lawless, destructive, dangerous, and cruel.
It is illegal.
It is unconstitutional.
It’s nothing less than Project 2025 by another name.
Congress must act.
CellChorus retweeted
CellChorus announced that the company, along with The University of Houston, has been awarded up to $2.5 million in funding. houston.innovationmap.com/un…
CellChorus retweeted
In Brief This Week: Bruker, Qiagen, Prenetics, CellChorus, T2 Biosystems, More genomeweb.com/business-news/…
CellChorus retweeted
Attending #SITC24 this week?Be sure to check out the 𝒇𝒐𝒖𝒓 presentations featuring data from @CellChorus' single-cell analysis technology! cellchorus.com/news/four-abs…
CellChorus retweeted
Immunotherapy is a powerful tool in fighting cancer, but not all patients respond.
However, a team of cancer researchers has recently discovered a new subset of T cells with the @CELLCHORUS (S21) TIMING platform that could improve outcomes for patients: houston.innovationmap.com/ce…
CellChorus retweeted
Check out the latest articles @NatureCancer "Identification of a clinically efficacious CAR T cell subset in diffuse large B cell lymphoma by dynamic multidimensional single-cell profiling" doi.org/10.1038/s43018-024-0…
CellChorus retweeted
Dynamic functional profiling of T-cell therapies uncover a subset of T cells, labeled CD8-fit, that are motile serial killers and are associated with clinical responses in diffuse B cell lymphoma patients.
nature.com/articles/s43018-0…
(No Paywall) singlecell.chee.uh.edu/wp-co…
CellChorus retweeted
YC S21's @CellChorus has received $2.5 million in support from @ncats_nih_gov @NIH to extend its TIMING™ single-cell analysis platform that quantifies which immune cells perform best and why.
genomeweb.com/business-news/…
CellChorus retweeted
Don't miss out! Register for @BTInnovator's application information session on November 28th at 9am PST and get all your application questions answered.
Register here: us06web.zoom.us/webinar/regi…
CellChorus retweeted
.@CellChorus has announced the the 2023 TIMING™ Grant Challenge, which seeks applicants w/ research, development & manufacturing projects that will benefit from dynamic single-cell analysis and present a significant innovation or advance in human health. cellchorus.com/2023-challeng…
CellChorus retweeted
Outstanding presentation by Dr. Sunil Acharya @sunilacharya13 on his work with CD70 targeting CAR constructs at the #NK2023 meeting in Oslo. Incredibly proud of his achievements, which have now been translated to the clinic @MDAndersonNews #nk
#endcancer
CellChorus retweeted
.@CellChorus is presenting at the @ISCTglobal North America Regional Meeting September 8-10 in Houston, Texas. CellChorus provides comprehensive, dynamic analysis of single cells. Details and registration >>> isctglobal.org/isctna2023/pr…
CellChorus retweeted
.@CellChorus is a perfect example of how #tech giants are embracing the marriage between #computation and #biology. It's exciting to see!
Congrats, team, on getting into the program!
Thank you to the @NVIDIA Inception team for their support! @CellChorus applies AI to evaluate how immune cells move, interact and perform over time
cellchorus.com/news/cellchor…
#ai #artificialIntelligence #ml #machineLearning #cellTherapy #immunotherapy #immunooncology #singleCell
CellChorus retweeted
CellChorus Wins Phase I National Science Foundation SBIR Grant. The award will support development of microscale arrays for single-cell analysis in the life sciences industry. ow.ly/mzc6104Mih9
CellChorus retweeted
The @NIH has awarded @CellChorus (YC S21) $2.3M to scale its visual AI technology that predicts cell response to life-saving immunotherapies, enabling scientists to create new medications faster, at lower cost, and with a higher success rate.
houston.innovationmap.com/ce…
CellChorus retweeted
A new dual-chimeric antigen receptor (CAR) system enhances the antitumor activity of CAR natural killer cells and makes them less susceptible to therapeutic #resistance in preclinical models. @lab_rezvani
#CARNK #therapyresistance
nature.com/articles/s41591-0…
CellChorus retweeted
Incredibly proud of Ye Ethan Li for having his PhD project published in Nat Med. His paper shows that trogocytosis drives relapse post CAR NK therapy & that modulating NK signaling can improve CAR NK efficacy. Congratulations Ethan! @KenChen @UH_NVLab
nature.com/articles/s41591-0…
CellChorus retweeted
Multidimensional single-cell analysis identifies a role for CD2-CD58 interactions in clinical antitumor T cell responses: buff.ly/3QwQIZO
@UH_NVLab @UHouston
#Immunology #Oncology
CellChorus retweeted
Using the TIMING method, @MDAndersonNews researchers profiled interactions between T cells that comprise patient infusion products and tumors, emphasizing the importance of studying T cell tumor cell interactions in identifying antitumor responses. bit.ly/3zuqXCP